Michael Borrie

Polygenic effects on the risk of Alzheimer’s disease in the Japanese population

Raymond Scott Turner, Sherye A. Sirrel, Alice D. Brown, 2024, Alzheimer's research & therapy.

Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment, cerebrovascular disease and Parkinson disease: A cross sectional and longitudinal study

Melissa F. Holmes, R. Swartz, M. Jog, 2024, International Journal of Geriatric Psychiatry.

Perivascular spaces, plasma GFAP, and speeded executive function in neurodegenerative diseases

R. Swartz, E. Rogaeva, M. Tartaglia, 2024, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Nanoscale flow cytometry-based quantification of blood-based extracellular vesicle biomarkers distinguishes MCI and Alzheimer's disease.

J. Wells, A. Roseborough, K. Coleman, 2024, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Impact of amyloid and cardiometabolic risk factors on prognostic capacity of plasma neurofilament light chain for neurodegeneration

Sherye A. Sirrel, Alice D. Brown, Christina A. Michel, 2024, Alzheimer's research & therapy.

Health System Change for Alzheimer's Disease-Modifying Therapies in Canada: Beginning the Discussion.

L. Verret, Michael Borrie, Zahinoor Ismail, 2023, The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques.